Additionally, intratumoral injections of LVs encoding shRNA specific for TGF-β1 after pretreatment with CY significantly increased the effectiveness of DC-based therapies in mice bearing MC38 colon carcinoma. The gene discussed is TGFB1; the disease is colon carcinoma.